STOCKSCREENR

0QW0.L

LSE

argenx SE

$661.80+11.50(+1.77%)Mkt Cap: $25.13B

Key Stats

Market Cap

$25.13B

P/E Ratio

-101.04

EPS

$-6.55

Dividend Yield

0.00%

52-Week Range

$456.80 — $809.80

Volume

11.55K

Avg Volume

38.66K

Beta

0.53

Price Alerts for 0QW0.L

Get alerted when 0QW0.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-101.04

Forward P/E

—

PEG Ratio

2.64

P/S (TTM)

15.23

P/B (TTM)

6.97

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

0.17%

ROA (TTM)

0.13%

ROIC

—

Gross Margin

0.89%

Operating Margin

0.26%

Net Margin

—

Debt/Equity

0.01

Current Ratio

5.23

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+1.10%

EPS Growth (5Y)

+0.37%

Sales Growth (3Y)

+0.86%

Sales Growth (5Y)

+2.63%

EPS Est (This Year)

$0.00

EPS Est (Next Year)

—

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$72.30

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

37.97M

Float

61.14M

Free Float %

161.02%

About

Sector

Healthcare

Industry

Biotechnology

Country

NL

Exchange

LSE

IPO Date

2015-11-30

Employees

1599

CEO

Timothy Van Hauwermeiren

Index Membership

—

Website

https://www.argenx.com

argenx SE (0QW0.L) is a healthcare company in the biotechnology industry listed on the LSE. With a market capitalization of $25.13B, a P/E ratio of -101.04, 0QW0.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0QW0.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

NUVL

Nuvalent, Inc.

$100.28

+1.19%

$7.34B

ARGX

argenx SE

$781.72

+0.73%

$48.38B

0HI3.L

Arrowhead Pharmaceuticals, Inc.

$73.15

+5.70%

$10.01B

RNAM

Avidity Biosciences Inc

$72.86

+0.05%

$10.63B

ROIV

Roivant Sciences Ltd.

$28.53

+3.67%

$20.42B

ASND

Ascendis Pharma A/S

$229.38

+4.13%

$14.08B

Frequently Asked Questions

What is argenx SE's P/E ratio?

argenx SE (0QW0.L) has a trailing twelve-month (TTM) P/E ratio of -101.04. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does argenx SE pay a dividend?

No, argenx SE (0QW0.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is argenx SE's market cap?

argenx SE (0QW0.L) has a market capitalization of $25.13 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.